SELLAS Life Sciences Group, Inc. (SLS)

7.78 +0.22 (+2.91%) USD  |  NASDAQ  |  May 22, 16:00
7.78 0.00 (0.00%) After-Hours: 20:00
More

SELLAS Life Sciences Group EBITDA (Quarterly)

EBITDA (Quarterly) Chart

View EBITDA (Quarterly) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (Quarterly) Range, Past 5 Years

View EBITDA (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (Quarterly) Benchmarks

View EBITDA (Quarterly) Benchmarks
Start Trial
Rezolute, Inc. Upgrade
Krystal Biotech, Inc. Upgrade
Spero Therapeutics, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
Whitehawk Therapeutics, Inc. Upgrade